PPAR Gamma Agonist Leriglitazone Recovers Alterations Due to Pank2-Deficiency in hiPS-Derived Astrocytes

The novel brain-penetrant peroxisome proliferator-activated receptor gamma agonist leriglitazone, previously validated for other rare neurodegenerative diseases, is a small molecule that acts as a regulator of mitochondrial function and exerts neuroprotective, anti-oxidative and anti-inflammatory ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Santambrogio, Paolo, Cozzi, Anna, Di Meo, Ivano, Cavestro, Chiara, Vergara, Cristina, Rodríguez-Pascau, Laura, Martinell, Marc, Pizcueta, Pilar, Tiranti, Valeria, Levi, Sonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862015/
https://www.ncbi.nlm.nih.gov/pubmed/36678831
http://dx.doi.org/10.3390/pharmaceutics15010202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862015/
https://www.ncbi.nlm.nih.gov/pubmed/36678831
http://dx.doi.org/10.3390/pharmaceutics15010202

Ejemplares similares